Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.18p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.15
  • 52 Week Low: 0.93
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 902,054
  • Market Cap: £14.18m
  • Beta: 0.00

FDA accepts Polarean's medical imaging drug-device resubmission

By Josh White

Date: Wednesday 20 Apr 2022

LONDON (ShareCast) - (Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon' gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine.
The AIM-traded firm said the United States Food and Drug Administration (FDA) accepted the resubmission of its new drug application (NDA) as a complete response.

It said the FDA established a user fee goal date of 30 September 2022.

"We are happy that the FDA has accepted our resubmission and look forward to resuming the review process with them in the expanded context of our response," said chief executive officer Richard Hullihen.

At 1221 BST, shares in Polarean Imaging were up 0.4% at 55.22p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

POLX Market Data

Currency UK Pounds
Share Price 1.18p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.15
52 Week Low 0.93
Volume 902,054
Shares Issued 1,207.03m
Market Cap £14.18m
Beta 0.00

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average

POLX Dividends

No dividends found

Trades for 27-May-2025

Time Volume / Share Price
16:10 17,500 @ 1.12p
15:57 16,670 @ 1.20p
15:16 26,419 @ 1.12p
15:11 9,221 @ 1.12p
15:07 18,129 @ 1.12p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page